secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-05-19T21:07:21+00:00
Accession:  0001193125-26-231083
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health exchanges $22.7M in royalty interests for Series Q Preferred Stock
--------------------------------------------------------------------------------

- Uptown Capital: $12.5M royalty reduction for 500 Series Q shares.
- Streeterville: $3.7M reduction (148 shares) + $6.5M reduction (260 shares).
- Series Q carries 10% annual preferred return payable in additional Series Q shares.
- Company can exchange Series Q for common at Minimum Price; 9.99% ownership cap.
- Restrictive covenants include equity issuance limit and majority-holder consent rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526231083/0001193125-26-231083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526231083/d227929d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-231083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer